Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: Marshall Teitelbaum who wrote (1794)	4/14/1999 1:06:00 AM
From: Rick Strange	Read Replies (1) \| Respond to of 2205

Marshall, One of the points made by Gail Naughton when taking about cartilage on CNBC was that their partner Smith&Nephew was number one in the area of orthopedic surgery. For S&N this is a win-win situation, not only do they get to sell the cartilage but tons of special instruments to perform the arthroscopic surgery. Regarding your comments about managed care...arthroscopic surgery and a short hospital stay would be very attractive to them as an alternative to whole joint replacement.